Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth P Lerner

Showing results (11-20 of 293) with videos related to

Pageof 30
Sort By:
Nature Clinical Practice. Urology|August 12, 2006
Treatment of high-risk, non-muscle-invasive bladder cancerSeth P Lerner
Nature Reviews. Urology|July 6, 2016
Bladder cancer: ASCO endorses EAU muscle-invasive bladder cancer guidelinesSeth P Lerner
Current Treatment Options in Oncology|July 1, 2009
The role and extent of pelvic lymphadenectomy in the management of patients with invasive urothelial carcinomaSeth P Lerner
Urology|October 12, 2010
Editorial commentSeth P Lerner
Urologic Oncology|September 9, 2008
Pathologic assessment and clinical significance of prostatic involvement by transitional cell carcinoma and prostate cancerSeth P Lerner, Steven Shen
The New England Journal of Medicine|February 18, 2026
Enfortumab Vedotin plus Pembrolizumab as Perioperative TherapyParminder Singh, Seth P Lerner
Cancer|August 19, 2014
Novel endoscopic diagnosis for bladder cancerSeth P Lerner, Alvin Goh
Bladder Cancer (Amsterdam, Netherlands)|August 22, 2017
Editorial Concerning "Impact of the Level of Urothelial Carcinoma Involvement of the Prostate on Survival after Radical Cystectomy"Steven Shen, Seth P Lerner
Oncology (Williston Park, N.Y.)|February 6, 2008
Neoadjuvant chemotherapy for bladder cancerGuru Sonpavde, Seth P Lerner
JCO Precision Oncology|August 3, 2023
Poly (ADP-ribose) Polymerase Inhibition in Advanced Urothelial CarcinomaAbhishek Tripathi, Seth P Lerner
Pageof 30

Showing results (11-20 of 293) with videos related to

Sort By:
Pageof 30
Nature Clinical Practice. Urology|August 12, 2006
Treatment of high-risk, non-muscle-invasive bladder cancerSeth P Lerner
Nature Reviews. Urology|July 6, 2016
Bladder cancer: ASCO endorses EAU muscle-invasive bladder cancer guidelinesSeth P Lerner
Current Treatment Options in Oncology|July 1, 2009
The role and extent of pelvic lymphadenectomy in the management of patients with invasive urothelial carcinomaSeth P Lerner
Urology|October 12, 2010
Editorial commentSeth P Lerner
Urologic Oncology|September 9, 2008
Pathologic assessment and clinical significance of prostatic involvement by transitional cell carcinoma and prostate cancerSeth P Lerner, Steven Shen
The New England Journal of Medicine|February 18, 2026
Enfortumab Vedotin plus Pembrolizumab as Perioperative TherapyParminder Singh, Seth P Lerner
Cancer|August 19, 2014
Novel endoscopic diagnosis for bladder cancerSeth P Lerner, Alvin Goh
Bladder Cancer (Amsterdam, Netherlands)|August 22, 2017
Editorial Concerning "Impact of the Level of Urothelial Carcinoma Involvement of the Prostate on Survival after Radical Cystectomy"Steven Shen, Seth P Lerner
Oncology (Williston Park, N.Y.)|February 6, 2008
Neoadjuvant chemotherapy for bladder cancerGuru Sonpavde, Seth P Lerner
JCO Precision Oncology|August 3, 2023
Poly (ADP-ribose) Polymerase Inhibition in Advanced Urothelial CarcinomaAbhishek Tripathi, Seth P Lerner
Pageof 30